MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis
- PMID: 23396164
- DOI: 10.1016/j.clinbiochem.2013.01.024
MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis
Erratum in
-
Corrigendum to "MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis" [Clinical Biochemistry 46 (2013) 918-925].Clin Biochem. 2019 Jan;63:162. doi: 10.1016/j.clinbiochem.2018.11.014. Epub 2018 Dec 14. Clin Biochem. 2019. PMID: 30559003 No abstract available.
-
Corrigendum to "MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis" Clinical Biochemistry 46 (2013) 918-925.Clin Biochem. 2019 Jun;68:58. doi: 10.1016/j.clinbiochem.2019.05.004. Epub 2019 May 23. Clin Biochem. 2019. PMID: 31128843 No abstract available.
Abstract
Lung cancer is the leading cause of cancer deaths worldwide and few genetic markers enable to evaluate lung cancer risk. MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression during various cell processes such as apoptosis, differentiation and development. In these last years, many works confirm a role for miRNAs in the initiation and progression of lung cancer. miRNA profiling has the potential to classify tumors with high accuracy and predict outcome. Here, we describe the roles of miRNA in lung carcinogenesis and the possibility to use them as biological markers for diagnostic, prognostic and predictive purposes.
Copyright © 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical